kidneycan Profile Banner
KidneyCAN Profile
KidneyCAN

@kidneycan

Followers
2K
Following
6K
Media
1K
Statuses
5K

Our mission is to accelerate cures for #kidneycancer. We educate patients about clinical trials, advocate for research funding, and bring researchers together.

United States
Joined December 2018
Don't wanna be here? Send us removal request.
@kidneycan
KidneyCAN
3 days
That's a wrap on #KCRS25!. Thank you to everyone who joined us, whether you were with us in Boston or tuning in virtually from around the world. Your presence, questions, and passion for collaboration made this year’s summit one to remember. Until next time, keep pushing the
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
8
29
@kidneycan
KidneyCAN
3 days
RT @CancerNetwrk: 🎥 And that's a wrap on #KCRS2025 🎥. Look out for more coverage to come on our website!. #kcsm | @kidneycan .
0
1
0
@kidneycan
KidneyCAN
3 days
RT @HHammersMD: Look at some of the impact of DOD CDMRP funding. @BraunMDPhD is presenting the personalized vaccine in RCC published in @Na….
0
13
0
@kidneycan
KidneyCAN
3 days
RT @Clara__Steiner: A sharp and insightful talk at #KCRS25 about KIM-1 in JAVELIN Renal 101 by my dear colleague @MarcMachaalani — another….
0
7
0
@kidneycan
KidneyCAN
3 days
We're honored to present the KidneyCAN Hall of Fame Award to Dr. Marston Linehan of the National Cancer Institute. Dr. Linehan pioneered the study of the genetic basis of kidney cancer. His team’s work identifying the genes and pathways that drive kidney cancer has transformed
Tweet media one
0
1
16
@kidneycan
KidneyCAN
3 days
RT @montypal: Proud of @ruchia_upenn, a @Penn undergraduate who spent her summers working with us at @cityofhope. Today she presented her w….
0
9
0
@kidneycan
KidneyCAN
3 days
RT @bergsa83: 🔔KEYNOTE-B61 longest follow up (3 years!) for papillary, chromophobe , translocation and unclassified RCC. Congrats to @Albi….
0
10
0
@kidneycan
KidneyCAN
3 days
RT @ReneeSaliby: Updated KEYNOTE-B61 data with a 50% ORR and durable responses in patient with variant histology RCC. A lot of hope for 1st….
0
11
0
@kidneycan
KidneyCAN
3 days
RT @arihakimi: So proud of my lab representing at #KCRS2025… Amazing meeting with amazing people!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
9
0
@kidneycan
KidneyCAN
3 days
RT @montypal: Many thanks to @NaomiHaas5 @PennCancer for discussing @WesleyYipMD @cityofhope's adjuvant trial of pembro + #CBM588 - the sub….
0
9
0
@kidneycan
KidneyCAN
3 days
RT @ReneeSaliby: What a panel for Oral Presentation session! Starting with a phenomenal presentation by @DrChoueiri on combininh cabo+casda….
0
6
0
@kidneycan
KidneyCAN
3 days
RT @markballmd: #KCRS25 is an amazing meeting for many reasons, but watching an illustrator draw your talk as you give it very cool. https:….
0
6
0
@kidneycan
KidneyCAN
3 days
We’re proud to present the KidneyCAN Catalyst Award to Dr. Rana McKay of UC San Diego. Dr. McKay is a leader whose work has helped move the field of kidney cancer forward through groundbreaking research, clinical collaboration, and a deep commitment to patients and advocacy. Her
Tweet media one
2
10
53
@kidneycan
KidneyCAN
3 days
RT @CancerNetwrk: 🎙️ We spoke with A. Ari Hakimi, MD, about some presentations on rarer forms of kidney cancer shared at #KCRS2025 🎙️ . Loo….
0
1
0
@kidneycan
KidneyCAN
3 days
RT @CancerNetwrk: 🚨 Eric Jonasch, MD, spoke about the Kidney Cancer Research Consortium in an interview with CancerNetwork at the #KCRS2025….
0
1
0
@kidneycan
KidneyCAN
3 days
RT @CancerNetwrk: 🎥 We had a great conversation with Praful Ravi, MB, BChir, MRCP, at #KCRS2025 about the phase 2 LASER trial. 🎥. Coverage….
0
1
0
@kidneycan
KidneyCAN
3 days
#KCRS25 Session 6 highlighted how researchers are pushing the boundaries of what immunotherapy can do for kidney cancer patients. Engaging Native Immunity with ENPP3 with Chuck Drake.TCR-Engineered Cell Therapy with @RosaNadalrios.Next Generation T-Cell Engineering with
Tweet media one
Tweet media two
0
1
6
@kidneycan
KidneyCAN
3 days
#KCRS25 Session 5 focused on current best practices and what's ahead in kidney cancer treatment and research. Front-Line Treatment Approaches with David McDermott.Subsequent-Line Options with @motzermd.Adjuvant Therapy Options with @NaomiHaas5.Treatment of Rare Subtypes with
Tweet media one
Tweet media two
0
3
10
@kidneycan
KidneyCAN
3 days
Huge thanks to @EisaiUS for sponsoring this year’s Rock the Run! Your support helps us fund the research that leads to better treatments for people facing kidney cancer. We’re grateful to have you on this journey with us. #RockTheRun #KCRS25 #AcceleratingCures @EisaiGlobalOnc
Tweet media one
Tweet media two
Tweet media three
0
0
12
@kidneycan
KidneyCAN
3 days
RT @ReneeSaliby: Takeaways from @VincentWenxinXu 's majestic talk on biomarkers:.- Several biomarkers have been studied in RCC.- Current bi….
0
11
0